Daré Bioscience Enters into Exclusive Worldwide License Agreement for Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform
pharmaceutical-investing Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
pharmaceutical-investing Data Monitoring Committee Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study
pharmaceutical-investing Sorrento and Celularity to Start Anti-CD38 CAR-T Phase 1 Clinical Trial in Patients With Relapsed or Refractory Multiple Myeloma
pharmaceutical-investing Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
pharmaceutical-investing Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
